Apiam Animal Health Ltd
ASX:AHX
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
AU |
Apiam Animal Health Ltd
ASX:AHX
|
67.7m AUD | 0.8 | ||
US |
Cigna Corp
NYSE:CI
|
99.3B USD | 0.6 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 0.6 | |
US |
CVS Health Corp
NYSE:CVS
|
69.4B USD | 0.3 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.2B USD | 1.6 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 1.2 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 2 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 1.1 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.3B EUR | 1.1 | ||
US |
DaVita Inc
NYSE:DVA
|
12.1B USD | 1.7 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.6 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.